Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis
剂量上限的 volasertib 抑制 PLK1 对 MDS 和 sAML 有显著疗效，同时还能保护健康的造血功能
期刊:European Journal of Haematology
影响因子:2.3
doi:10.1111/ejh.13354
Veronika Dill, Johanna Kauschinger, Richard T Hauch, Lars Buschhorn, Timo O Odinius, Catharina Müller-Thomas, Ritu Mishra, Michele C Kyncl, Burkhard Schmidt, Peter M Prodinger, Dirk Hempel, Frauke Bellos, Alexander Höllein, Wolfgang Kern, Torsten Haferlach, Julia Slotta-Huspenina, Florian Bassermann
